Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's Net Income towards Common Stockholders rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 825.4%. This contributed to the annual value of -$38.5 million for FY2024, which is 679.9% up from last year.
  • As of Q3 2025, Jaguar Health's Net Income towards Common Stockholders stood at -$9.6 million, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Net Income towards Common Stockholders peaked at -$7.6 million during Q4 2022, and registered a low of -$18.0 million during Q1 2022.
  • For the 5-year period, Jaguar Health's Net Income towards Common Stockholders averaged around -$11.1 million, with its median value being -$10.6 million (2025).
  • Over the last 5 years, Jaguar Health's Net Income towards Common Stockholders had its largest YoY gain of 4703.42% in 2022, and its largest YoY loss of 4977.1% in 2022.
  • Over the past 5 years, Jaguar Health's Net Income towards Common Stockholders (Quarter) stood at -$14.3 million in 2021, then soared by 47.03% to -$7.6 million in 2022, then fell by 20.96% to -$9.2 million in 2023, then dropped by 11.6% to -$10.2 million in 2024, then grew by 5.73% to -$9.6 million in 2025.
  • Its Net Income towards Common Stockholders was -$9.6 million in Q3 2025, compared to -$10.6 million in Q2 2025 and -$10.6 million in Q1 2025.